AKT1 and pachyonychia congenita: Recent studies have demonstrated that knocking down fat mass and obesity-related proteins (FTOs) can reduce NEDD4 expression and therefore significantly increase the level of PTEN expression, with a consequent effect on the PI3K/AKT pathway, which results in PC cells being resistant to gemcitabine, leading to a poor prognosis.